Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review

Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology international 2024-07, Vol.44 (7), p.1359-1367
Hauptverfasser: Jovicic, Zikica, Dragasevic, Sanja, Petkovic, Ana, Plesinac, Snezana, Sokic Milutinovic, Aleksandra, Stojanovic, Maja
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1367
container_issue 7
container_start_page 1359
container_title Rheumatology international
container_volume 44
creator Jovicic, Zikica
Dragasevic, Sanja
Petkovic, Ana
Plesinac, Snezana
Sokic Milutinovic, Aleksandra
Stojanovic, Maja
description Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn’s disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn’s disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen.
doi_str_mv 10.1007/s00296-023-05440-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2860401295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2860401295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-c990d952132925e2b3ce22364e2816ac38bafc4e27c23981257b6abd1e858a2f3</originalsourceid><addsrcrecordid>eNp9UUuP1iAUbYzGeegfcGFI3LgY9AItbd1NJr6SSVw4Ju4IpbczjC1ULnX8_o6_VPQbH3Hh4sAFzj0HOFX1SMAzAdA-JwDZaw5ScWjqGjjcqQ5FrVouNHy8-1d9UB0RXQOIVmu4Xx2oVjcKNBxW395vziHRtM1sTXgZbHAeifnALFtt9hgyu_H5il3YT3ZnaWM2ZUw-e2I2jAXZr1eRCma_-pHRLowpLnjCFutDLsCRxVAUp9l_9YsdmIspexep6EQ_8ikhsuLtFwwvmLOEfCjDWPa-eLx5UN2b7Ez48HY-rj68enlx9oafv3v99uz0nDsldeau72HsGymU7GWDclAOpVS6RtkJbZ3qBju5smqdVH0nZNMO2g6jwK7prJzUcfV0r7um-HlDymbx5HCebcC4kZGdhhqE7JtCffIP9TpuKZTbmfKtXXEVbV9Ycs9yKRIlnMyayvvTzggwPxI0-wRNSdD8TNBAaXp8K70NC46_W35FVghqT6ByFC4x_fH-j-x3Mn6p5Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3068236179</pqid></control><display><type>article</type><title>Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Jovicic, Zikica ; Dragasevic, Sanja ; Petkovic, Ana ; Plesinac, Snezana ; Sokic Milutinovic, Aleksandra ; Stojanovic, Maja</creator><creatorcontrib>Jovicic, Zikica ; Dragasevic, Sanja ; Petkovic, Ana ; Plesinac, Snezana ; Sokic Milutinovic, Aleksandra ; Stojanovic, Maja</creatorcontrib><description>Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn’s disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn’s disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen.</description><identifier>ISSN: 1437-160X</identifier><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-023-05440-0</identifier><identifier>PMID: 37653060</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Antiphospholipid Syndrome - complications ; Antiphospholipid Syndrome - diagnosis ; Antiphospholipid Syndrome - drug therapy ; Autoimmune diseases ; Azathioprine - therapeutic use ; Case Based Review ; Crohn Disease - complications ; Crohn Disease - drug therapy ; Crohn's disease ; Female ; Humans ; Immunosuppressive Agents - therapeutic use ; Infliximab - therapeutic use ; Live Birth ; Medicine ; Medicine &amp; Public Health ; Monoclonal antibodies ; Patients ; Pregnancy ; Pregnancy Outcome ; Rheumatology ; Steroids ; Takayasu Arteritis - complications ; Takayasu Arteritis - drug therapy</subject><ispartof>Rheumatology international, 2024-07, Vol.44 (7), p.1359-1367</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-c990d952132925e2b3ce22364e2816ac38bafc4e27c23981257b6abd1e858a2f3</cites><orcidid>0000-0002-2292-5181 ; 0000-0003-1944-3883 ; 0000-0002-3450-1765 ; 0000-0001-5513-854X ; 0000-0003-4589-7344 ; 0000-0002-8805-8391</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00296-023-05440-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00296-023-05440-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37653060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jovicic, Zikica</creatorcontrib><creatorcontrib>Dragasevic, Sanja</creatorcontrib><creatorcontrib>Petkovic, Ana</creatorcontrib><creatorcontrib>Plesinac, Snezana</creatorcontrib><creatorcontrib>Sokic Milutinovic, Aleksandra</creatorcontrib><creatorcontrib>Stojanovic, Maja</creatorcontrib><title>Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><addtitle>Rheumatol Int</addtitle><description>Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn’s disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn’s disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen.</description><subject>Adult</subject><subject>Antiphospholipid Syndrome - complications</subject><subject>Antiphospholipid Syndrome - diagnosis</subject><subject>Antiphospholipid Syndrome - drug therapy</subject><subject>Autoimmune diseases</subject><subject>Azathioprine - therapeutic use</subject><subject>Case Based Review</subject><subject>Crohn Disease - complications</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn's disease</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infliximab - therapeutic use</subject><subject>Live Birth</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Monoclonal antibodies</subject><subject>Patients</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Rheumatology</subject><subject>Steroids</subject><subject>Takayasu Arteritis - complications</subject><subject>Takayasu Arteritis - drug therapy</subject><issn>1437-160X</issn><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UUuP1iAUbYzGeegfcGFI3LgY9AItbd1NJr6SSVw4Ju4IpbczjC1ULnX8_o6_VPQbH3Hh4sAFzj0HOFX1SMAzAdA-JwDZaw5ScWjqGjjcqQ5FrVouNHy8-1d9UB0RXQOIVmu4Xx2oVjcKNBxW395vziHRtM1sTXgZbHAeifnALFtt9hgyu_H5il3YT3ZnaWM2ZUw-e2I2jAXZr1eRCma_-pHRLowpLnjCFutDLsCRxVAUp9l_9YsdmIspexep6EQ_8ikhsuLtFwwvmLOEfCjDWPa-eLx5UN2b7Ez48HY-rj68enlx9oafv3v99uz0nDsldeau72HsGymU7GWDclAOpVS6RtkJbZ3qBju5smqdVH0nZNMO2g6jwK7prJzUcfV0r7um-HlDymbx5HCebcC4kZGdhhqE7JtCffIP9TpuKZTbmfKtXXEVbV9Ycs9yKRIlnMyayvvTzggwPxI0-wRNSdD8TNBAaXp8K70NC46_W35FVghqT6ByFC4x_fH-j-x3Mn6p5Q</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Jovicic, Zikica</creator><creator>Dragasevic, Sanja</creator><creator>Petkovic, Ana</creator><creator>Plesinac, Snezana</creator><creator>Sokic Milutinovic, Aleksandra</creator><creator>Stojanovic, Maja</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2292-5181</orcidid><orcidid>https://orcid.org/0000-0003-1944-3883</orcidid><orcidid>https://orcid.org/0000-0002-3450-1765</orcidid><orcidid>https://orcid.org/0000-0001-5513-854X</orcidid><orcidid>https://orcid.org/0000-0003-4589-7344</orcidid><orcidid>https://orcid.org/0000-0002-8805-8391</orcidid></search><sort><creationdate>20240701</creationdate><title>Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review</title><author>Jovicic, Zikica ; Dragasevic, Sanja ; Petkovic, Ana ; Plesinac, Snezana ; Sokic Milutinovic, Aleksandra ; Stojanovic, Maja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-c990d952132925e2b3ce22364e2816ac38bafc4e27c23981257b6abd1e858a2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Antiphospholipid Syndrome - complications</topic><topic>Antiphospholipid Syndrome - diagnosis</topic><topic>Antiphospholipid Syndrome - drug therapy</topic><topic>Autoimmune diseases</topic><topic>Azathioprine - therapeutic use</topic><topic>Case Based Review</topic><topic>Crohn Disease - complications</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn's disease</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infliximab - therapeutic use</topic><topic>Live Birth</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Monoclonal antibodies</topic><topic>Patients</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Rheumatology</topic><topic>Steroids</topic><topic>Takayasu Arteritis - complications</topic><topic>Takayasu Arteritis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jovicic, Zikica</creatorcontrib><creatorcontrib>Dragasevic, Sanja</creatorcontrib><creatorcontrib>Petkovic, Ana</creatorcontrib><creatorcontrib>Plesinac, Snezana</creatorcontrib><creatorcontrib>Sokic Milutinovic, Aleksandra</creatorcontrib><creatorcontrib>Stojanovic, Maja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jovicic, Zikica</au><au>Dragasevic, Sanja</au><au>Petkovic, Ana</au><au>Plesinac, Snezana</au><au>Sokic Milutinovic, Aleksandra</au><au>Stojanovic, Maja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review</atitle><jtitle>Rheumatology international</jtitle><stitle>Rheumatol Int</stitle><addtitle>Rheumatol Int</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>44</volume><issue>7</issue><spage>1359</spage><epage>1367</epage><pages>1359-1367</pages><issn>1437-160X</issn><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn’s disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn’s disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>37653060</pmid><doi>10.1007/s00296-023-05440-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-2292-5181</orcidid><orcidid>https://orcid.org/0000-0003-1944-3883</orcidid><orcidid>https://orcid.org/0000-0002-3450-1765</orcidid><orcidid>https://orcid.org/0000-0001-5513-854X</orcidid><orcidid>https://orcid.org/0000-0003-4589-7344</orcidid><orcidid>https://orcid.org/0000-0002-8805-8391</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1437-160X
ispartof Rheumatology international, 2024-07, Vol.44 (7), p.1359-1367
issn 1437-160X
0172-8172
1437-160X
language eng
recordid cdi_proquest_miscellaneous_2860401295
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Antiphospholipid Syndrome - complications
Antiphospholipid Syndrome - diagnosis
Antiphospholipid Syndrome - drug therapy
Autoimmune diseases
Azathioprine - therapeutic use
Case Based Review
Crohn Disease - complications
Crohn Disease - drug therapy
Crohn's disease
Female
Humans
Immunosuppressive Agents - therapeutic use
Infliximab - therapeutic use
Live Birth
Medicine
Medicine & Public Health
Monoclonal antibodies
Patients
Pregnancy
Pregnancy Outcome
Rheumatology
Steroids
Takayasu Arteritis - complications
Takayasu Arteritis - drug therapy
title Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T13%3A09%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20pregnancies%20in%20a%20patient%20with%20Takayasu%20arteritis%20and%20antiphospholipid%20syndrome,%20maintained%20on%20infliximab%20corticosteroid-free%20regimen:%20case-based%20review&rft.jtitle=Rheumatology%20international&rft.au=Jovicic,%20Zikica&rft.date=2024-07-01&rft.volume=44&rft.issue=7&rft.spage=1359&rft.epage=1367&rft.pages=1359-1367&rft.issn=1437-160X&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-023-05440-0&rft_dat=%3Cproquest_cross%3E2860401295%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3068236179&rft_id=info:pmid/37653060&rfr_iscdi=true